Croma-Pharma Gesellschaft M.B.H.
Croma-Pharma Gesellschaft M.B.H., commonly referred to as Croma, is a leading player in the pharmaceutical and aesthetic medicine industry, headquartered in Austria (AT). Founded in 2003, the company has established a strong presence in Europe and beyond, specialising in innovative medical products and aesthetic solutions. Croma is renowned for its high-quality dermal fillers and advanced biotechnological products, which are designed to enhance beauty and improve skin health. The company’s commitment to research and development has positioned it as a pioneer in the field, with a focus on safety and efficacy that sets its offerings apart from competitors. With a robust market position, Croma has achieved significant milestones, including numerous certifications and awards that underscore its dedication to excellence in the aesthetic sector.
DitchCarbon Score
How does Croma-Pharma Gesellschaft M.B.H.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Croma-Pharma Gesellschaft M.B.H.'s score of 26 is lower than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Croma-Pharma Gesellschaft M.B.H.'s reported carbon emissions
Croma-Pharma Gesellschaft M.B.H., headquartered in Austria (AT), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Croma-Pharma's climate commitments and initiatives remain unclear, and there is no information available regarding their strategies for addressing carbon emissions or contributing to sustainability efforts. Without emissions data or reduction initiatives, it is challenging to assess their environmental impact or commitment to climate action within the industry context.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Croma-Pharma Gesellschaft M.B.H. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
